Abstract
Obinutuzumab (Gazyva) and High-Dose Methylprednisolone (HDMP) Combination for Patients with Chronic Lymphocytic Leukemia (CLL) - a Phase Ib/II Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have